RhumbLine Advisers’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-196,773
| Closed | -$787K | – | 2951 |
|
|
2019
Q4 | $787K | Buy |
196,773
+11,181
| +6% | +$44.7K | ﹤0.01% | 2184 |
|
|
2019
Q3 | $909K | Buy |
185,592
+11,779
| +7% | +$57.7K | ﹤0.01% | 2078 |
|
|
2019
Q2 | $1.06M | Buy |
173,813
+13,863
| +9% | +$84.5K | ﹤0.01% | 2049 |
|
|
2019
Q1 | $929K | Sell |
159,950
-1,486
| -0.9% | -$8.63K | ﹤0.01% | 2072 |
|
|
2018
Q4 | $2.17M | Buy |
161,436
+28,901
| +22% | +$389K | ﹤0.01% | 1593 |
|
|
2018
Q3 | $2.57M | Buy |
132,535
+8,606
| +7% | +$167K | 0.01% | 1522 |
|
|
2018
Q2 | $3.17M | Buy |
123,929
+7,800
| +7% | +$199K | 0.01% | 1402 |
|
|
2018
Q1 | $2.34M | Buy |
116,129
+2,803
| +2% | +$56.5K | ﹤0.01% | 1510 |
|
|
2017
Q4 | $2.27M | Buy |
113,326
+15,713
| +16% | +$315K | ﹤0.01% | 1555 |
|
|
2017
Q3 | $2.02M | Buy |
97,613
+4,925
| +5% | +$102K | ﹤0.01% | 1621 |
|
|
2017
Q2 | $1.37M | Buy |
92,688
+6,738
| +8% | +$99.7K | ﹤0.01% | 1778 |
|
|
2017
Q1 | $1.37M | Buy |
85,950
+24,076
| +39% | +$384K | ﹤0.01% | 1762 |
|
|
2016
Q4 | $780K | Buy |
61,874
+2,873
| +5% | +$36.2K | ﹤0.01% | 1988 |
|
|
2016
Q3 | $1.65M | Buy |
59,001
+6,775
| +13% | +$190K | ﹤0.01% | 1532 |
|
|
2016
Q2 | $1.83M | Buy |
52,226
+9,924
| +23% | +$347K | 0.01% | 1400 |
|
|
2016
Q1 | $1.16M | Buy |
42,302
+6,765
| +19% | +$185K | ﹤0.01% | 1696 |
|
|
2015
Q4 | $1.22M | Buy |
35,537
+3,550
| +11% | +$121K | ﹤0.01% | 1676 |
|
|
2015
Q3 | $919K | Buy |
31,987
+1,382
| +5% | +$39.7K | ﹤0.01% | 1821 |
|
|
2015
Q2 | $1.37M | Buy |
30,605
+19,405
| +173% | +$869K | ﹤0.01% | 1666 |
|
|
2015
Q1 | $387K | Buy |
11,200
+3,150
| +39% | +$109K | ﹤0.01% | 2455 |
|
|
2014
Q4 | $220K | Buy |
+8,050
| New | +$220K | ﹤0.01% | 2754 |
|